Pharmaceutical / Drug Definition :
Thought to inhibit DNA synthesis by acting as purine analog. Also causes alkylation and may interact with sulfhydryl groups
FDA Detentions
Dacarbazine (Dacarbazine Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Dacarbazine (Dacarbazine Suppliers)
- Processors Dacarbazine
- Repackers Dacarbazine
- Relabelers Dacarbazine
- Exporters Dacarbazine
- Importers Dacarbazine
For more information about Dacarbazine, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
